The global radiofrequency ablation market to grow at a CAGR of 8.78% during the period 2017-2021.
The report, Global Radiofrequency Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.
The latest trend gaining momentum in the market is new product launches coupled with R&D activities. Vendors are increasingly focusing on the development and launch of new radiofrequency ablation devices. Product launches and R&D activities will help vendors survive in the market and enhance their growth. Vendors such as Medtronic, Boston Scientific, AngioDynamics, and Merit Medical Systems are actively involved in the development of innovative devices for improving the efficacy of radiofrequency ablation procedures.
According to the report, one of the major drivers for this market is increasing incidence of chronic disorders and growing older population. A sedentary lifestyle can negatively affect the homeostasis of the body. The dietary habits of people worldwide are changing, which make them susceptible to many disorders such as cardiovascular diseases, respiratory diseases, obesity, cancer, urology disorders, joint pain, Alzheimer's disease, and other chronic illnesses. According to the CDC data, the number of people with chronic disorders has been increasing steadily over the past two decades. So, the emphasis and focus on treatments for these diseases such as radiofrequency ablation have increased. Radiofrequency ablation devices are increasingly used to treat chest pain, joint pain, gynecological conditions, and liver and kidney problems.